Changes in serum C-PTH, serum ALP, and subjective symptoms during oral 1.ALPHA., 25(OH)2D3 pulse therapy and conventional therapy in hemodialysis patients with secondary hyperparathyroidism.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.